Comparison between Anlon Healthcare IPO and Ganesh Consumer Products IPO.
Anlon Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Ganesh Consumer Products IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Anlon Healthcare IPO is up to ₹121.03 Cr whereas the issue size of the Ganesh Consumer Products IPO is up to ₹408.80 Cr. The final issue price of Anlon Healthcare IPO is ₹91.00 per share and of Ganesh Consumer Products IPO is ₹322.00 per share.
| Anlon Healthcare IPO | Ganesh Consumer Products IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹86.00 per share | ₹306.00 per share |
| Issue Price (Upper) | ₹91.00 per share | ₹322.00 per share |
| Issue Price (Final) | ₹91.00 per share | ₹322.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹30.00 per share | |
| Market Lot Size | 164 shares | 46 shares |
| Fresh Issue Size | 1,33,00,000 shares | 40,39,687 shares |
| Fresh Issue Size (Amount) | up to ₹121.03 Cr | up to ₹130.05 Cr |
| OFS Issue Size | 0 shares | 86,58,333 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹278.75 Cr |
| Issue Size Total | 1,33,00,000 shares | 1,26,98,020 shares |
| Issue Size Total (Amount) | up to ₹121.03 Cr | up to ₹408.80 Cr |
Anlon Healthcare IPO opens on Aug 26, 2025, while Ganesh Consumer Products IPO opens on Sep 22, 2025. The closing date of Anlon Healthcare IPO and Ganesh Consumer Products IPO is Aug 29, 2025, and Sep 24, 2025, respectively.
| Anlon Healthcare IPO | Ganesh Consumer Products IPO | |
|---|---|---|
| Anchor Bid Date | Aug 25, 2025 | Sep 19, 2025 |
| Issue Open | Aug 26, 2025 | Sep 22, 2025 |
| Issue Close | Aug 29, 2025 | Sep 24, 2025 |
| Basis Of Allotment (Tentative) | Sep 01, 2025 | Sep 25, 2025 |
| Initiation of Refunds (Tentative) | Sep 02, 2025 | Sep 26, 2025 |
| Credit of Share (Tentative) | Sep 02, 2025 | Sep 26, 2025 |
| Listing date (Tentative) | Sep 03, 2025 | Sep 29, 2025 |
| Anchor Lockin End date 1 | Oct 01, 2025 | Oct 24, 2025 |
| Anchor Lockin End date 2 | Nov 30, 2025 | Dec 23, 2025 |
Anlon Healthcare IPO P/E ratio is 17.67, as compared to Ganesh Consumer Products IPO P/E ratio of 33.06.
| Anlon Healthcare IPO | Ganesh Consumer Products IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Anlon Healthcare Ltd.'s revenue increased by 81% and profit after tax (PAT) rose by 112% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Ganesh Consumer Products Ltd.'s revenue increased by 12% and profit after tax (PAT) rose by 31% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 70.26 | 75.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 52.68 | 64.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.67 | 33.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹483.68 Cr. | ₹1301.22 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 40.45% | 15.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.93% | 19.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.73 | 0.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.15 | ₹9.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 25.51% | 15.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anlon Healthcare IPO Retail Individual Investors (RII) are offered 13,30,000 shares while in Ganesh Consumer Products IPO retail investors are offered 13,30,000 shares. Qualified Institutional Buyers (QIB) are offered 99,75,000 shares in Anlon Healthcare IPO and 25,32,909 shares in Ganesh Consumer Products IPO.
| Anlon Healthcare IPO | Ganesh Consumer Products IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 37,99,362 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 99,75,000 shares | 25,32,909 shares |
| NII | 19,95,000 shares | 18,99,682 shares |
| RII | 13,30,000 shares | 44,32,591 shares |
| Employee | 0 shares | 34,246 shares |
| Others | ||
| Total | 1,33,00,000 shares | 1,26,98,790 shares |
Anlon Healthcare IPO subscribed 7.12x in total, whereas Ganesh Consumer Products IPO subscribed 2.68x.
| Anlon Healthcare IPO | Ganesh Consumer Products IPO | |
|---|---|---|
| QIB (times) | 1.07x | 4.03x |
| NII (times) | 10.61x | 4.41x |
| Big NII (times) | 7.56x | 5.73x |
| Small NII (times) | 16.69x | 1.77x |
| RII (times) | 47.26x | 1.17x |
| Employee (times) | 2.14x | |
| Other (times) | ||
| Total (times) | 7.12x | 2.68x |
